Total synthesis of englerin A

Area of Science:

• Organic Chemistry
• Medicinal Chemistry
• Cancer Research

Background:

• Englerin A is a sesquiterpenoid with demonstrated potent and selective growth inhibition against renal cancer cell lines.
• The development of efficient synthetic routes is crucial for further biological evaluation and drug discovery.

Purpose of the Study:

• To achieve the total synthesis of englerin A.
• To explore the structure-activity relationships of englerin A and its analogs against cancer cell lines.

Main Methods:

• The synthesis employed a key [5 + 2] cycloaddition reaction to construct the core seven-membered oxabicyclic intermediate.
• Both racemic and optically active forms of the intermediate were synthesized.
• Several analogs, including englerin B, englerin B acetate, and others, were synthesized and tested.

Main Results:

• The total synthesis of englerin A was successfully accomplished.
• The cytotoxicity of synthetic englerin A and its analogs was evaluated against a panel of cancer cell lines.
• The results provide valuable data for future structure-activity relationship (SAR) studies.

Conclusions:

• The successful total synthesis of englerin A provides a platform for further investigation.
• The cytotoxicity data obtained from englerin A and its analogs guide future medicinal chemistry efforts.
• This work facilitates focused SAR studies to optimize the anticancer potential of englerin A derivatives.